2025 ICD-10-CM code M32.9
(Active) Effective Date: N/A Revision Date: N/A Deletion Date: N/A Musculoskeletal and Connective Tissue Diseases - Systemic connective tissue disorders Chapter 13: Diseases of the musculoskeletal system and connective tissue Feed
Systemic lupus erythematosus (SLE), unspecified.This code is used when the type of SLE is not specified.
Modifiers may be applicable depending on the specific circumstances and the services rendered. Consult local guidelines for modifier use.
Medical necessity for coding M32.9 is established through comprehensive clinical documentation demonstrating the presence of symptoms and findings consistent with SLE.Laboratory results must corroborate the diagnosis, justifying the need for medical management and monitoring.
The clinical responsibility encompasses a thorough history taking, physical examination, ordering and interpreting relevant laboratory tests (CBC, ANA, urinalysis, biopsies), and formulating a diagnosis of SLE.Treatment may involve managing symptoms with medications like analgesics, NSAIDs, corticosteroids, anticoagulants, and/or biologics. Ongoing monitoring and management of SLE's effects on different organ systems are crucial.
- Chapter 13: Diseases of the musculoskeletal system and connective tissue
- M32 Systemic lupus erythematosus
In simple words: This code indicates a type of lupus, a disease where the body's immune system attacks its own tissues.The doctor hasn't specified which type of lupus it is or which body parts are affected.Lupus can cause pain, swelling, rashes, fatigue, and problems with many organs.
This ICD-10-CM code, M32.9, signifies unspecified systemic lupus erythematosus (SLE). SLE is a chronic autoimmune disease where the body's immune system mistakenly attacks its own tissues and organs.The "unspecified" designation means that the specific type or organ involvement of SLE has not been documented.This can include a wide range of symptoms affecting various parts of the body, including joints, skin, kidneys, heart, lungs, and nervous system. Diagnosis relies on patient history, physical examination, and lab tests like complete blood count (CBC), antinuclear antibody (ANA) test, urinalysis, and biopsies.
Example 1: A 35-year-old female presents with fatigue, joint pain, and a characteristic malar rash (butterfly rash).Laboratory tests reveal positive ANA and low complement levels.The physician diagnoses SLE, but the extent of organ involvement is not yet determined., A 40-year-old male with a history of SLE experiences a flare-up with increased joint pain and inflammation. He is admitted for observation and treatment.The specific organ affected is the joints., A 28-year-old female presents with symptoms suggestive of SLE, including fatigue, skin lesions, and mild kidney involvement.Further investigation is needed to confirm the diagnosis and determine the extent of organ damage.
Complete patient history detailing symptoms, onset, duration, and progression.Results of relevant laboratory tests (CBC, ANA, complement levels, urinalysis, kidney function tests), imaging studies (if performed), and biopsy reports (if done).Physician's assessment summarizing findings and diagnosis.
** The unspecified nature of this code necessitates comprehensive documentation to support the diagnosis and justify the medical necessity of treatment and procedures.
- Payment Status: Active
- Specialties:Rheumatology, Internal Medicine, Nephrology, Dermatology
- Place of Service:Office, Hospital Inpatient, Hospital Outpatient